4.6 Article

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities

M. Simbolo et al.

Summary: Thirteen cases of combined small-cell lung cancer (C-SCLC) were evaluated, showing potential targetable alterations and distinct transcriptomic profiles, which could be classified into different subtypes based on NE or non-NE lineage.

ESMO OPEN (2022)

Article Oncology

External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer

Fengwei Tan et al.

Summary: This study provided external validation of the eighth edition of the TNM classification for lung cancer in Chinese patients with small cell lung cancer (SCLC) and confirmed its improved prognostic accuracy compared with the seventh edition. The study also identified N3 and M1b as potentially heterogeneous populations that warrant further research.

LUNG CANCER (2022)

Article Oncology

Primary tumor surgery improves survival of cancer patients with synchronous solitary bone metastasis: a large population-based study

Wei Wu et al.

Summary: The study found that primary tumor surgery was associated with improved survival in cancer patients with bone metastasis. Breast, bladder, renal, and lung cancer patients experienced prolonged median survival times of 20 months, 3 months, 4 months, and 21 months, respectively, after surgery.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Oncology

Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database

Lan Yang et al.

Summary: This study revealed that patients with Combined small-cell lung cancer (CSCLC) had a worse prognosis compared to non-small cell lung cancer (NSCLC) patients, but a comparable prognosis to pure small cell lung cancer (SCLC) patients in matched cohorts. A nomogram was developed to predict the survival rate of CSCLC patients.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Review Oncology

Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature

Chi Leung Chiang et al.

Summary: This study conducted a systematic review to identify prognostic factors in nasopharyngeal carcinoma (NPC) and suggested changes to the current TNM classification. The proposed changes with strong evidence included upstaging paranasal sinus, defining parotid lymph node as N3, and incorporating non-TNM factors like EBV-DNA level. Further validation studies are needed to confirm the significance of these factors.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?

Xiaoliang Zhao et al.

JOURNAL OF THORACIC ONCOLOGY (2018)